E1724. Endovascular Thrombectomy and Stent Reconstruction for Venous Occlusive Disease
  1. Andrew Woerner; University of Washington
  2. Christopher Ingraham; University of Washington
  3. Eric Monroe; University of Wisconsin
  4. David Shin; University of Washington
  5. Ethan Hua; University of Washington
  6. Sandeep Vaidya; University of Washington
  7. Jeffrey Chick; University of Washington
Deep venous thrombosis is often treated with anticoagulation alone and the initial symptoms of pain and swelling can progress to chronic and debilitating post-thrombotic syndrome. Venous occlusive disease can be due to benign or malignant causes and can be graded on chronicity and severity. Common benign causes are long term central venous access, caval interruption, and extrinsic compression. Malignant causes are usually due to tumoral extension or invasion. With the development of available technology, the prior paradigm of treating venous occlusive disease, both acute and chronic is changing rapidly.

Educational Goals / Teaching Points
The goals of this educational exhibit are to review patient selection for intervention; evaluate pre-procedural imaging; review current thrombectomy device landscape and novel dedicated venous stents; present intra-procedural imaging; and discuss recanalization, thrombectomy, and stent reconstruction techniques.

Key Anatomic/Physiologic Issues and Imaging Findings/Techniques
Review of imaging will describe findings to delineate acute and chronic venous occlusive disease. Interventional techniques will include blunt and sharp recanalization, catheter-directed thrombolysis and thrombectomy, endovenous tissue sampling, and stent reconstruction.

Thrombectomy and stent reconstruction are important techniques in the management of symptomatic venous occlusive disease. There are a variety of advanced interventional techniques available to reconstruct central venous flow and treat patients with symptomatic venous occlusive disease safely and effectively.